Hill Research CAIO Rui Wu Showcases "TheraGPT" at Biotech Showcase During JPM Week
Boston, MA — January 2025 — Hill Research, a trailblazer in AI-driven solutions for the clinical trial and pharmaceutical industries, is proud to announce that its Chief AI Officer, Rui Wu, delivered an insightful presentation on the groundbreaking capabilities of TheraGPT at the Biotech Showcase during JPMorgan Healthcare Week in San Francisco.
TheraGPT, Hill Research’s flagship AI platform, represents a significant leap forward in transforming the clinical trial landscape. Combining the power of generative AI and real-world patient data, TheraGPT enables pharmaceutical companies and CROs to streamline patient recruitment, optimize protocol design, and improve predictive modeling for trial outcomes. With a foundation built on Hill Research’s proprietary large language model trained on 150 billion tokens, TheraGPT is uniquely positioned to address some of the industry’s most pressing challenges.
In his presentation, Rui Wu highlighted the key features and applications of TheraGPT, emphasizing its ability to:
Accelerate patient recruitment by analyzing vast datasets to identify eligible candidates with unprecedented accuracy.
Support protocol optimization by offering predictive insights tailored to trial objectives.
Leverage LLM-driven reasoning to enhance decision-making across trial phases.
“TheraGPT is not just an AI platform; it’s a catalyst for innovation in the clinical trial industry,” said Rui Wu. “Our mission at Hill Research is to empower pharmaceutical leaders with the tools they need to bring life-saving treatments to patients faster and more efficiently.”
Following the presentation, Rui Wu engaged in dynamic discussions with a diverse group of investors and industry leaders. These dialogues explored the significant potential of TheraGPT to revolutionize drug development by addressing inefficiencies and reducing time-to-market for new therapies. The constructive exchanges underscored the growing recognition of AI as a transformative force in healthcare innovation.
The Biotech Showcase, a cornerstone event during JPM Week, provides a global platform for biotech and pharmaceutical leaders to share pioneering technologies, foster partnerships, and discuss the future of life sciences.
About Hill Research
Hill Research is a leading provider of AI-powered analytics solutions, specializing in GenAI-based data analytics and process automation for clinical trials and drug development. Collaborating with industry leaders such as Eli Lilly, Moderna, and Bayer, Hill Research leverages real-world patient data and cutting-edge AI to drive breakthroughs in human health.
